WORLDREMIT
4.2.2021 02:56:08 CET | Business Wire | Press release
WorldRemit, a leading digital cross-border payments business has announced the winners of its recent Grainsmart store franchise promotion to help customers give their beneficiaries the opportunity to start a business in the Philippines. Customers qualified for the promotion by sending money to the Philippines and nominating a beneficiary of their choice. The winners include frontline healthcare workers and teachers from a number of countries including the United Kingdom, Norway, Australia, Canada, New Zealand, Sweden and the United States. Beneficiaries will now be opening Grainsmart stores across the Philippines in places which include Cebu, Davao, San Carlos and Tagum City.
“We’re so pleased to give recipients this great opportunity to start a business that will help them to support their families and become more financially stable. The franchisees have the option to expand these businesses and potentially create job opportunities for members of the wider community. This underlines our commitment to helping Overseas Filipino Workers to support those dearest to them back home,” said Earl Melivo, Country Director for the Philippines at WorldRemit.
Benjamin Batac, CEO at Grainsmart added, “It’s an honour to partner with a company like WorldRemit that shares our values. With many of the franchise contracts already signed, this promotion will create sustainable jobs and also give much-needed support to Filipino farmers, many of whom are facing challenges due to the pandemic and recent natural disasters”.
Winner Emilie Ann Estavas who works as a healthcare assistant in a care home in Oxfordshire said, “I’m very happy and excited with the prize and so grateful to WorldRemit and Grainsmart. It is really a surprise. The Pangkabuhayan package will help my family back in the Philippines to start a business which is a huge blessing and a big help. It is a great opportunity and I’m planning to expand the business while we are here still working abroad. I am hoping and praying that God will bless the business and make it prosper so that in the near future it will help us to retire early, go home and continue running the business with my family. Fingers crossed!”.
Winner and frontline worker Melissa Zibas has chosen her cousin Adan who lives in San Carlos City, Pangasinan as her beneficiary. She said, “Adan is a former seafarer and is pretty adventurous like me so I know he’ll make a huge success of the Grainsmart business. We’re a very close family so I hope we can grow the business and include other members of our family. The covid-19 pandemic has really tested everyone's lives so it's great to start a business that will be needed by people as rice is our staple food”.
Rosa Mae who lives in Norway and is studying to become a youth worker, chose her sister Rhea as her beneficiary. Rhea who lives and works in Tagum City as a doctor’s secretary said, “I’m so grateful to my big sister for giving me this opportunity. I miss her so much now that she lives over 10,000 miles away in Oslo. Sending transfers through WorldRemit is her way of supporting and staying connected to us and now it has given me the chance to start my own business. We grew up in Davao de Oro and our parents still live there so I’m looking forward to running the Grainsmart franchise with them”.
Each Grainsmart franchise business package includes:
- 60 sacks (25 kg each) of rice
- A tablet that’s fully set up for a bills payment center account
- Business signage, marketing collateral, and other business paraphernalia
- An online training and mentorship program – to provide guidance for setting up the business for success
As well as the COVID-19 pandemic, Filipinos have also had to deal with the devastation caused by Super Typhoon Goni and Typhoon Vamco, which have displaced thousands and destroyed livelihoods.
Take advantage of competitive exchange rates for the Philippine peso by visiting www.worldremit.com or downloading the app.
Winners were announced on the WorldRemit Facebook page (https://www.facebook.com/WorldRemit/ ).
For more details visit www.worldremit.com/pangkabuhayan .
WorldRemit
WorldRemit is a leading digital cross-border payments business. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from more than 50 countries to 130+ receive countries, operate in 6,500 money transfer corridors worldwide and employ over 1,100 people worldwide.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
For more information visit www.worldremit.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210203006021/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
